Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
Patients In the Intermediate Size Patient Population Expanded Access (EA) Program Will Receive Intranasal Foralumab As Part of the At-Home Dosing ...
Williama Clementi Irina Koffler Tanuja Chitnis Paul Spencer Gabriele Cerrone Professor Of Neurology At Harvard Medical School
Source: businessinsider.com